Meeting
2018 ASCO Annual Meeting
The utility of genomics and functional imaging to predict Sunitinib PK and PD: The Predict SU study.
Authors
Michael Michael
Division of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne, Australia
Michael Michael , David William Pook , Vinod Ganju , Emma Link , Guy C. Toner , Rodney J Hicks , Anetta Matera , Mick Thompson , Carleen Cullinane , Ian Campbell , Matthew Burge , Christos Stelios Karapetis
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Developmental Therapeutics—Clinical Pharmacology and Experimental Therapeutics
Track
Developmental Therapeutics and Translational Research
Sub Track
Pharmacology
Clinical Trial Registration Number
ACTRN12610000897066
Citation
J Clin Oncol 36, 2018 (suppl; abstr 2563)
DOI
10.1200/JCO.2018.36.15_suppl.2563
Abstract #
2563
Poster Bd #
389
Abstract Disclosures
Similar Posters
Poster
2017 ASCO Annual Meeting
The utility of genomics and functional imaging to predict irinotecan pharmacokinetics and pharmacodynamics: The PREDICT IR study.
First Author: Michael Michael
Poster
2014 ASCO Annual Meeting
Dose adjustment of axitinib based on AUC monitoring in sunitinib-refractory advanced renal cell carcinoma.
First Author: Yuji Miura
First Author: Nielka P van Erp
Poster
2013 ASCO Annual Meeting
Association analysis of polymorphisms in genes related to sunitinib pharmacokinetics.
First Author: Meta Diekstra